RaDaR is now open to a new Cohort of patients – Monoclonal Gammopathy of Renal Significance (MGRS) – which covers the following conditions:
- AH amyloidosis
- AHL amyloidosis
- AL amyloidosis
- C3 glomerulonephritis with monoclonal gammopathy
- (Cryo)crystalglobulin-induced nephropathy
- Crystal-storing histiocytosis
- Fibrillary Glomerulonephritis
- Immunotactoid/Glomerulonephritis with Monoclonal Immunoglobulin Deposits (GOMMID)
- Light chain cast nephropathy
- Light chain Fanconi Syndrome
- Monoclonal Immunoglobulin Deposition Disease
- Proliferative glomerulonephritis with monoclonal immunoglobulin deposits – PGNMID
- Proximal tubulopathy without crystals
- Thrombotic Microangiopathy with monoclonal gammopathy
- Type 1 cryoglobulinaemic Glomerulonephritis
No new approvals are needed to start recruiting these patients.
A Crib Sheet of details of the conditions that are included in the MGRS cohort is available to download from https://tinyurl.com/mgrs-crib-sheet or from request via Melanie.Dillon@renalregistry.nhs.uk
